Results of a multicentre UK-wide study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the pre-transplant naive setting

Research output: Contribution to journalMeeting Abstractpeer-review

21 Downloads (Pure)
Original languageEnglish
JournalHematological oncology
Volume35
Issue numberS1
Publication statusPublished - 7 Jun 2017

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Cite this